InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
NANJING, China, Nov. 21, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against cancer treatment resistance and metastasis, announced that China National Medical Products Administration (NMPA) has granted Ifebemtinib (IN10018) Breakthrough Therapy designation (BTD) for the first-line (1L) treatment of non-small cell lung cancer (NSCLC) with KRAS G12C mutation in combination with garsorasib, a...
APRIL Group Supports National Health Development in Riau Province, Indonesia
SINGAPORE, Nov. 21, 2024 /PRNewswire/ -- Leading pulp, paper and board producer APRIL Group has further strengthened its commitment to improving public health by donating essential medical equipment to a local health facility in Riau province in Sumatra, Indonesia, close to where the company's manufacturing operations are located. APRIL, a member of the RGE group of companies, provided 22 types...
DP Technology and Lepu Biopharma Announce Milestone Collaboration: Leveraging Advanced Computational Methods to Accelerate ADC Drug Innovation
This partnership has effectively integrated DP's ADC Linker-Payload design platform with Lepu's ADC technology development platform, capitalizing on their respective strengths. The overall optimization of the ADC drug has been achieved in a relatively short time. BEIJING, Nov. 20, 2024 /PRNewswire/ -- Lepu Biopharma Co., Ltd. (Lepu Biopharma) and Beijing DP Tech Co., Ltd. (DP Technology) have recently announced a...
United Imaging Installs Another Flagship uMR OMEGA®, in New Mexico
X-Ray Associates of New Mexico (XRANM), with their motto "We Don't Follow. We Lead.", took decisive action to have the 75 cm 3T MRI scanner installed and clinically operational within ten months of seeing images at RSNA 2023. HOUSTON, Nov. 21, 2024 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, recently installed...
Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
– Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in near-term milestone payments and opt-in right for solid tumors – – Companies to jointly develop and commercialize ziftomenib; 50/50 profit share in the U.S.; Kura to lead U.S. development and commercial activities...
Complete Genomics announces mpox virus amplicon sequencing panel at AMP
VANCOUVER, BC, Nov. 21, 2024 /PRNewswire/ -- Complete Genomics, a San Jose, Calif.-based genomic sequencer manufacturer, today announced at the 2024 Association for Molecular Pathology (AMP) Annual Meeting & Expo the launch of its mpox (MPXV) virus amplicon sequencing panel, part of its sequencing product portfolio for pathogenic microorganisms. Complete Genomics is at AMP this week at Booth #1524. The...
GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products
PLANTATION, Fla., Nov. 21, 2024 /PRNewswire/ -- GBI Biomanufacturing (GBI), one of the world's longest serving contract development and manufacturing organizations (CDMO), is pleased to announce the expansion of its Drug Product (DP) services, to include automated sterile fill and finish capabilities. GBI has the ability to support clients from clinical trials to commercial launch,...
NAYO Captivates Audiences at Analytica China 2024 with its Unique Exhibition Style
SHANGHAI, Nov. 20, 2024 /PRNewswire/ -- NAYO proudly participated in the 12th Analytica China & Labtech China Congress 2024, the international trade fair for laboratory technology, analysis and biotechnology in China. Breaking away from traditional exhibition norms, NAYO demonstrated its cutting-edge technology and flexible platform-based approach using a robotic arm extending up to 8 meters, capturing the attention of...
Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obesity
The collaboration will accelerate the global development of LAE102, a novel Activin Receptor Type 2 A (ActRIIA) Antagonistic Monoclonal Antibody (mAb) for muscle-preserving weight loss in Obesity LOS ANGELES, Nov. 20, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK) ("Laekna"), a global biotech company focused on novel drug development for metabolic and cancer diseases, is pleased to announce a clinical collaboration with...
FAIR PLAY MENARINI: THE NAMES OF THE PARTICIPANTS AT ‘THE CHAMPIONS TELL THEIR STORIES’ TALK SHOW ARE REVEALED
FLORENCE, Italy, Nov. 20, 2024 /PRNewswire/ -- The journey of the 28th Fair Play Menarini International Award continues. Following the spectacular award ceremony on 4 July, the event honouring the pinnacle of loyalty and fair play in sports concludes the year with the talk show The Champions Tell their Stories, to be held...
